Cargando…
Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature
Nail toxicities, such as paronychia and pyogenic granuloma-like lesions, are well-recognized side effects of epidermal growth factor receptor inhibitor (EGFR-I) therapy that can significantly impair patient’s quality of life and compliance to anticancer treatment. Numerous therapeutic options are av...
Autores principales: | Sollena, Pietro, Mannino, Maria, Tassone, Francesco, Calegari, Maria Alessandra, D’Argento, Ettore, Peris, Ketty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860413/ https://www.ncbi.nlm.nih.gov/pubmed/31798664 http://dx.doi.org/10.7573/dic.212613 |
Ejemplares similares
-
Topical brimonidine for pyogenic granuloma after paronychia surgery
por: Chen, Yusha, et al.
Publicado: (2020) -
Ibrutinib-Induced Paronychia and Periungual Pyogenic Granuloma
por: Alamri, Awadh, et al.
Publicado: (2022) -
Systemic Drug-induced Chronic Paronychia and Periungual Pyogenic Granuloma
por: Wollina, Uwe
Publicado: (2018) -
Ibrutinib-Associated Multifocal Paronychia with Periungual Pyogenic Granulomas Involving Concomitant Finger and Toe Nails
por: Kaur, Lovleen, et al.
Publicado: (2023) -
The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions
por: Bavetta, Mauro, et al.
Publicado: (2021)